Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DAVILA

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 15, 2022
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting CellsJustin C Boucher, Bin Yu, Gongbo Li, et al.
Plos One|April 10, 2014
A positive feedback mechanism that regulates expression of miR-9 during neurogenesisJonathan L Davila, Loyal A Goff, Christopher L Ricupero, et al.
Mucosal Immunology|August 11, 2020
Coordinated co-migration of CCR10<sup>+</sup> antibody-producing B cells with helper T cells for colonic homeostatic regulationLuming Zhao, Shaomin Hu, Micha L Davila, et al.
Nature|December 14, 2018
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndromeVerena Staedtke, Ren-Yuan Bai, Kibem Kim, et al.
Transplantation and Cellular Therapy|June 2, 2021
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell LymphomaAlbert Cortes-Bullich, Ariel Perez, Christina Bachmeier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 14, 2019
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting CellsBishwas Shrestha, Yongliang Zhang, Bin Yu, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Leukemia|February 12, 2026
Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphomaJing Gao, Xiaohong Zhao, Qing Yin, et al.
Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.
Experimental Hematology & Oncology|September 28, 2024
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancersHiroshi Kotani, Tomoyoshi Yamano, Justin C Boucher, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 15, 2022
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting CellsJustin C Boucher, Bin Yu, Gongbo Li, et al.
Plos One|April 10, 2014
A positive feedback mechanism that regulates expression of miR-9 during neurogenesisJonathan L Davila, Loyal A Goff, Christopher L Ricupero, et al.
Mucosal Immunology|August 11, 2020
Coordinated co-migration of CCR10<sup>+</sup> antibody-producing B cells with helper T cells for colonic homeostatic regulationLuming Zhao, Shaomin Hu, Micha L Davila, et al.
Nature|December 14, 2018
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndromeVerena Staedtke, Ren-Yuan Bai, Kibem Kim, et al.
Transplantation and Cellular Therapy|June 2, 2021
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell LymphomaAlbert Cortes-Bullich, Ariel Perez, Christina Bachmeier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 14, 2019
Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting CellsBishwas Shrestha, Yongliang Zhang, Bin Yu, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Leukemia|February 12, 2026
Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphomaJing Gao, Xiaohong Zhao, Qing Yin, et al.
Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.
Experimental Hematology & Oncology|September 28, 2024
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancersHiroshi Kotani, Tomoyoshi Yamano, Justin C Boucher, et al.
Pageof 10